Each capsule contains Tramadol hydrochloride 50 mg.
Moderate to severe acute or chronic pain and in painful diagnostic or therapeutic measures.
The dosage should be adjusted to the intensity of the pain. Unless otherwise prescribed, MATRADOL should be taken as follows independent of meals: Single dose for adults and adolescents over 14 years of age: 1 capsule to be taken with a little liquid.
This is usually sufficient to relieve the pain. If, however, pain relief is unsatisfactory, a further MATRADOL may be taken after about 30-60 minutes.
In general the daily dose should not exceed 8 capsules.
In impaired renal or hepatic function it may be necessary to reduce the dose as prescribed by physician.
Duration of treatment: During long-term treatment with MATRADOL the possibility of dependence cannot be entirely excluded. Therefore the physician is to decide on the duration of treatment and whether the preparation is to be withdrawn temporarily. MATRADOL should not be given for longer than therapeutically necessary.
Acute intoxication to alcohol, hypnotics, analgesics or other CNS-acting drugs.
Respiratory depression has so far not been observed during treatment with MATRADOL. However, it can not definitely be ruled out if the recommended dosage is considerably exceeded or on the concomitant administration of other centrally depressant drugs.
Even when taken according to instructions the preparation may affect the reaction ability of the patient to such an extent that his capacity to drive or operate machines may be impaired. This applies particularly in conjunction with alcohol.
The preparation should be used with care in patients with increased reactivity to opioids. Patients known to suffer from convulsions should be carefully monitored during treatment with MATRADOL.
Pregnancy: In accordance with currently prevailing recommendations medication with MATRADOL during pregnancy should only be considered to after careful consideration of the risks.
Lactation: On use during lactation it is to be taken into account that about 0.1% of the dose passes into the milk.
Sweating, dizziness, nausea, vomiting, dry mouth, and fatigue may occur after MATRADOL administration. Influence on cardiovascular regulation (e.g. palpitations, postural hypotension or cardiovascular collapse) has been observed in rare cases. Undesirable effects occur particularly when the patient is under physical strain. In isolated cases convulsions have been observed in connection with the administration of MATRADOL.
On the concomitant administration of MATRADOL with substances which also act on the central nervous system (e.g. tranquilizers, hypnotics) the sedative effect (fatigue) may be intensified. At the same time, however, combining MATRADOL with a tranquilizer for example, will probably have a favorable effect on pain sensation.
MATRADOL should not be used in patients receiving MAO inhibitors.
Preserve in tight - light resistant containers and store below 30°C.
N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain.
Matradol cap 50 mg
10 × 10's;50 × 10's
Sign Out
